CXCL8 and psoriasis: Considering the applicability of the CBD-loaded LSNs for the treatment of inflammatory conditions, and particularly for psoriasis, it was shown that CBD containing LSNs reduced TNF-α-induced release of pro-inflammatory cytokines, IL-6 and IL-8, in a HaCaT cell model when applied in combination with BSA as a release mediator.